According to MHT, Medrobotics Corp., has secured a Series D round of funding. The $8M round of equity, warrants and other options is part of a $20 million offering. A total of 18 investors have invested in the offering, according to an SEC filing.

Medrobotics Corporation (formerly Cardioborobotics, Inc.) is a Delaware "C" Corporation, originally formed in 2005 (as Innovention Technologies, LLC). Medrobotics has developed a platform of flexible medical robots that enable surgeons to access, visualize, and perform two-handed surgery in hard-to-reach anatomical places through a single-site access. The core technology is a new generation of flexible robotic snakes with advanced vision systems that are able to navigate tortuous paths while providing accessory channels for a wide range of flexible surgical tools. The robots are self-supporting, which means they are able to support their own weight and move within any three-dimensional space without the need for any other structural support.

Medrobotics has exclusive worldwide licenses for its technologies from Carnegie Mellon University and the University of Pittsburgh as well as additional robust development of its own intellectual property portfolio.